| Cayla Holmes, PA-C | |
|
5236 W University Dr Ste 2200, Mckinney, TX 75071-8113 | |
| (469) 800-5325 | |
| Not Available |
| Full Name | Cayla Holmes |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 6 Years |
| Location | 5236 W University Dr Ste 2200, Mckinney, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134698939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Cytokinetics, Incorporated announced today the publication of preclinical research in the March 18, 2011 issue of the journal Science regarding the activation of cardiac myosin by an investigational drug candidate, omecamtiv mecarbil, and the potential therapeutic role that this novel mechanism may play for patients with systolic heart failure.
Discovery Laboratories, Inc. a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today announces that it has entered into an agreement for a new investment of $0.5 million from PharmaBio Development Inc. (PharmaBio), the former strategic investing subsidiary of Quintiles Transnational Corp.
Long-term risks of invasive cancer and recurrence of severe cervical intraepithelial neoplasia (CIN) are higher among women previously treated for CIN, compared with those with no CIN diagnosis, according to data from a large, retrospective cohort study published in the May 12 online issue of the Journal of the National Cancer Institute
Researchers from Boston University School of Medicine, in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors, while improving urinary symptoms in patients with benign prostatic hyperplasia and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction, ejaculatory dysfunction and potential depression.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cayla Holmes, PA-C 5236 W University Dr Ste 2200, Mckinney, TX 75071-8113 Ph: (469) 800-5325 | Cayla Holmes, PA-C 5236 W University Dr Ste 2200, Mckinney, TX 75071-8113 Ph: (469) 800-5325 |
News Archive
Cytokinetics, Incorporated announced today the publication of preclinical research in the March 18, 2011 issue of the journal Science regarding the activation of cardiac myosin by an investigational drug candidate, omecamtiv mecarbil, and the potential therapeutic role that this novel mechanism may play for patients with systolic heart failure.
Discovery Laboratories, Inc. a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today announces that it has entered into an agreement for a new investment of $0.5 million from PharmaBio Development Inc. (PharmaBio), the former strategic investing subsidiary of Quintiles Transnational Corp.
Long-term risks of invasive cancer and recurrence of severe cervical intraepithelial neoplasia (CIN) are higher among women previously treated for CIN, compared with those with no CIN diagnosis, according to data from a large, retrospective cohort study published in the May 12 online issue of the Journal of the National Cancer Institute
Researchers from Boston University School of Medicine, in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors, while improving urinary symptoms in patients with benign prostatic hyperplasia and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction, ejaculatory dysfunction and potential depression.
› Verified 7 days ago
Mr. Trevor Fewins, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4201 Medical Center Dr Ste 100, Mckinney, TX 75069 Phone: 872-566-5255 | |
Thomas Chase Nash, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 4201 Medical Center Dr Ste 100, Mckinney, TX 75069 Phone: 469-796-4295 | |
Sarah Cunningham, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 6850 Tpc Dr Ste 100, Mckinney, TX 75070 Phone: 214-383-4400 | |
Jane Elizabeth Greenwood, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2709 Virginia Pkwy, Suite 100, Mckinney, TX 75071 Phone: 972-542-3300 Fax: 972-542-4311 | |
Nicole Williams, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4501 Medical Center Dr, Suite #200, Mckinney, TX 75069 Phone: 972-547-0352 Fax: 972-542-3528 | |
Ms. Erica R. Smith, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 7692 Eldorado Pkwy, Mckinney, TX 75070 Phone: 972-562-8388 Fax: 972-540-2219 | |
Heather Holly Boyd, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2760 Virginia Pkwy, Suite 100, Mckinney, TX 75071 Phone: 972-542-1180 Fax: 972-542-5395 |